Partnerships

>

Latest News

Zealand Pharma, Roche Reach Potential $5.3 Billion Deal to Develop Petrelintide for Weight Management
Zealand Pharma, Roche Reach Potential $5.3 Billion Deal to Develop Petrelintide for Weight Management

March 12th 2025

Partnership includes the development of combination products, including a fixed-dose combination of petrelintide and Roche’s dual GLP-1/GIP receptor agonist, CT-388, for weight management.

Viking Therapeutics, CordenPharma Strike Multi-Year Deal to Commercialize VK2735 for Obesity, Metabolic Disorders
Viking Therapeutics, CordenPharma Strike Multi-Year Deal to Commercialize VK2735 for Obesity, Metabolic Disorders

March 11th 2025

Astellas Pharma and Yaskawa Electric Sign Definitive Agreement to Launch New Cell Therapy Manufacturing Organization
Astellas Pharma and Yaskawa Electric Sign Definitive Agreement to Launch New Cell Therapy Manufacturing Organization

March 6th 2025

AbbVie, Gubra Strike Deal to Develop Novel Weight Loss Treatment
AbbVie, Gubra Strike Deal to Develop Novel Weight Loss Treatment

March 3rd 2025

Biogen, Stoke Therapeutics Ink Deal to Develop Zorevunersen for Dravet Syndrome
Biogen, Stoke Therapeutics Ink Deal to Develop Zorevunersen for Dravet Syndrome

February 20th 2025

More News